VIR Financials
Vir Biotechnology Inc - Financial statements & key metrics
Stock Price
$11.64
Market Cap
$1.45B
P/E Ratio
-3.0
EPS
$-3.83
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$74.20M
Gross Profit
-
Operating Income
-
Net Income
$-521.96M
EPS (Diluted)
$-3.83
Balance Sheet Highlights
Total Assets
$1.40B
Total Liabilities
$248.43M
Shareholders Equity
-
Cash & Equivalents
$222.95M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-446.35M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-703.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is VIR revenue?
VIR's most recent quarterly revenue was $74.20M. Annual revenue can be calculated by summing the four most recent quarters.
Is VIR profitable?
VIR reported a loss of $521.96M in the most recent quarter. The net profit margin is -703.4%.
What is VIR market cap?
VIR has a market capitalization of $1.45B, making it a small-cap stock.
Does VIR have debt?
View VIR's balance sheet for debt information.
What is VIR cash flow?
Cash flow data is available in the full financial statements.